Declerck PJ - Search Results

1

A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor.

Stanne TM, Olsson M, Lorentzen E, Pedersen A, Gummesson A, Gils A, Jood K, Engström G, Melander O, Declerck PJ, Jern C. Stanne TM, et al. Among authors: declerck pj. Thromb Haemost. 2018 Feb;118(2):298-308. doi: 10.1160/TH17-04-0249. Epub 2018 Jan 29. Thromb Haemost. 2018. PMID: 29378355 Free PMC article.

2

Fibrinolysis and coagulation in patients with infectious disease and sepsis.

Philippé J, Offner F, Declerck PJ, Leroux-Roels G, Vogelaers D, Baele G, Collen D. Philippé J, et al. Among authors: declerck pj. Thromb Haemost. 1991 Mar 4;65(3):291-5. Thromb Haemost. 1991. PMID: 1904655

3

Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop.

Gils A, Knockaert I, Declerck PJ. Gils A, et al. Among authors: declerck pj. Biochemistry. 1996 Jun 11;35(23):7474-81. doi: 10.1021/bi960079d. Biochemistry. 1996. PMID: 8652525

4

Proteinase specificity and functional diversity in point mutants of plasminogen activator inhibitor 1.

Gils A, Declerck PJ. Gils A, et al. Among authors: declerck pj. J Biol Chem. 1997 May 9;272(19):12662-6. doi: 10.1074/jbc.272.19.12662. J Biol Chem. 1997. PMID: 9139722 Free article.

5

Identification of positively charged residues contributing to the stability of plasminogen activator inhibitor 1.

Gils A, Lu J, Aertgeerts K, Knockaert I, Declerck PJ. Gils A, et al. Among authors: declerck pj. FEBS Lett. 1997 Sep 29;415(2):192-5. doi: 10.1016/s0014-5793(97)01122-8. FEBS Lett. 1997. PMID: 9350994 Free article.

6

Modulation of plasminogen activator inhibitor 1 by Triton X-100--identification of two consecutive conformational transitions.

Gils A, Declerck PJ. Gils A, et al. Among authors: declerck pj. Thromb Haemost. 1998 Aug;80(2):286-91. Thromb Haemost. 1998. PMID: 9716154

7

Characterization of plasminogen activator inhibitor 1 mutants containing the P13 to P10 region of ovalbumin or antithrombin III: evidence that the P13 residue contributes significantly to the active to substrate transition.

Gils A, Vleugels N, Tobback K, Knockaert I, Declerck PJ. Gils A, et al. Among authors: declerck pj. Biochim Biophys Acta. 1998 Sep 8;1387(1-2):291-7. doi: 10.1016/s0167-4838(98)00139-3. Biochim Biophys Acta. 1998. PMID: 9748634

8

Structure-function relationships in serpins: current concepts and controversies.

Gils A, Declerck PJ. Gils A, et al. Among authors: declerck pj. Thromb Haemost. 1998 Oct;80(4):531-41. Thromb Haemost. 1998. PMID: 9798964 Review. No abstract available.

9

Immunological quantitation of rabbit plasminogen activator inhibitor-1 in biological samples: evidence that rabbit platelets do not contain PAI-1.

Ngo TH, Declerck PJ. Ngo TH, et al. Among authors: declerck pj. Thromb Haemost. 1999 Nov;82(5):1510-5. Thromb Haemost. 1999. PMID: 10595646

10

The importance of helix F in plasminogen activator inhibitor-1.

Vleugels N, Gils A, Bijnens AP, Knockaert I, Declerck PJ. Vleugels N, et al. Among authors: declerck pj. Biochim Biophys Acta. 2000 Jan 3;1476(1):20-6. doi: 10.1016/s0167-4838(99)00224-1. Biochim Biophys Acta. 2000. PMID: 10606763

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

270 results

Search Page

Filters